Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 24;13(23):5906.
doi: 10.3390/cancers13235906.

Mutation Profile Variability in the Primary Tumor and Multiple Pulmonary Metastases of Clear Cell Renal Cell Carcinoma. A Review of the Literature and Analysis of Four Metastatic Cases

Affiliations
Review

Mutation Profile Variability in the Primary Tumor and Multiple Pulmonary Metastases of Clear Cell Renal Cell Carcinoma. A Review of the Literature and Analysis of Four Metastatic Cases

Kristyna Prochazkova et al. Cancers (Basel). .

Abstract

(1) Background: There are limited data concerning inter-tumoral and inter-metastatic heterogeneity in clear cell renal cell carcinoma (CCRCC). The aim of our study was to review published data and to examine mutation profile variability in primary and multiple pulmonary metastases (PMs) in our cohort of four patients with metastatic CCRCC. (2) Methods: Four patients were enrolled in this study. The clinical characteristics, types of surgeries, histopathologic results, immunohistochemical and genetic evaluations of corresponding primary tumor and PMs, and follow-up data were recorded. (3) Results: In our series, the most commonly mutated genes were those in the canonically dysregulated VHL pathway, which were detected in both primary tumors and corresponding metastasis. There were genetic profile differences between primary and metastatic tumors, as well as among particular metastases in one patient. (4) Conclusions: CCRCC shows heterogeneity between the primary tumor and its metastasis. Such mutational changes may be responsible for suboptimal treatment outcomes in targeted therapy settings.

Keywords: clear cell renal cell carcinoma; inter-metastatic heterogeneity; inter-tumoral heterogeneity; intra-tumoral heterogeneity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. López J.I. Renal Tumors with Clear Cells. A Review. Pathol. Res. Pract. 2013;209:137–146. doi: 10.1016/j.prp.2013.01.007. - DOI - PubMed
    1. Moch H., Humphrey P.H., Ulbright T.M., Reuter V.E., editors. WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th ed. IARC; Lyon, France: 2016. 356p - PubMed
    1. Ljungberg B., Bensalah K., Canfield S., Dabestani S., Hofmann F., Hora M., Kuczyk M.A., Lam T., Marconi L., Merseburger A.S., et al. EAU Guidelines on Renal Cell Carcinoma: 2014 Update. Eur. Urol. 2015;67:913–924. doi: 10.1016/j.eururo.2015.01.005. - DOI - PubMed
    1. Procházková K., Vodička J., Fichtl J., Krákorová G., Šebek J., Roušarová M., Hošek P., Brookman May S.D., Hes O., Hora M., et al. Outcomes for Patients after Resection of Pulmonary Metastases from Clear Cell Renal Cell Carcinoma: 18 Years of Experience. Urol. Int. 2019;103:297–302. doi: 10.1159/000502493. - DOI - PubMed
    1. López J.I., Angulo J.C. Pathological Bases and Clinical Impact of Intratumor Heterogeneity in Clear Cell Renal Cell Carcinoma. Curr. Urol. Rep. 2018;19:3. doi: 10.1007/s11934-018-0754-7. - DOI - PubMed

LinkOut - more resources